Abstract
The ability of a large number of bacterial pathogens to multiply in the infected host and cause disease is dependent on their ability to express high affinity zinc importers. In many bacteria ZnuABC, a transporter of the ABC family, plays a central role in the process of zinc uptake in zinc poor environments, including the tissues of the infected host. To initiate an investigation into the relevance of the zinc uptake apparatus for Pseudomonas aeruginosa pathogenicity, we have generated a znuA mutant in the PA14 strain. We have found that this mutant strain displays a limited growth defect in zinc depleted media. The znuA mutant strain is more sensitive than the wild type strain to calprotectin-mediated growth inhibition, but both the strains are highly resistant to this zinc sequestering antimicrobial protein. Moreover, intracellular zinc content is not evidently affected by inactivation of the ZnuABC transporter. These findings suggest that P. aeruginosa is equipped with redundant mechanisms for the acquisition of zinc that might favor P. aeruginosa colonization of environments containing low levels of this metal. Nonetheless, deletion of znuA affects alginate production, reduces the activity of extracellular zinc-containing proteases, including LasA, LasB and Protease IV, and decreases the ability of P. aeruginosa to disseminate during systemic infections. These results indicate that efficient zinc acquisition is critical for the expression of various virulence features typical of P. aeruginosa and that ZnuABC also plays an important role in zinc homeostasis in this microorganism.
Introduction
A key feature of the host response to bacterial infections is the activation of strategies aimed at the sequestration of transition metals, such as iron, zinc and manganese, to starve microorganisms from nutrients which are essential for their growth1. In fact, metals are structural or catalytic cofactors in a wide number of proteins and a reduction in their intake may severely affect the ability of bacteria to multiply and produce virulence factors. The importance of these metals for bacterial physiology has been highlighted by bioinformatics studies which have indicated that about 4% of all bacterial proteins contain non-heme iron and 5-6% of these proteins contain zinc2, 3. Zinc, in particular, is present in enzymes from all six functional classes, including several enzymes participating to central metabolic pathways and a vast assortment of distinct cellular functions.
Strategies to hamper metal recruitment by infectious bacteria, include the release of metal sequestering proteins at mucosal sites of infection, and the activation of metal transport systems which removes metal ions not tightly bound to proteins from extracellular and specific intracellular compartments. To overcome such metal sequestration mechanisms, pathogens produce high affinity metal uptake systems which favor the recruitment of metals in environments where these elements are very scarce and enhance their proliferation in inflamed tissues1, 4. In most Gram-negative bacteria a central factor in the response to zinc deficiency is played the high affinity zinc uptake system ZnuABC5. ZnuABC is a member of the ATP-binding cassette-type class of transporters, whose expression is under the transcriptional control of Zur, a metalloregulatory DNA-binding protein with high sensitivity to free intracellular zinc6, 7. In several bacteria, including Brucella abortus8, Salmonella enterica9, 10 and Campylobacter jejuni11, deletion of the znuABC operon or of the gene encoding for ZnuA, the soluble periplasmic component of the transporter, is associated with major defects in growth in zinc poor media and to a dramatic loss of virulence. In other bacteria, additional zinc import systems contribute to metal import under zinc deficiency and disruption of znuABC is not associated to clear-cut phenotypes. For example, in response to zinc deficiency Neisseria meningitidis12, Yersinia pestis13, 14 and Acinetobacter baumannii15, 16 produce membrane channels which specifically favor the entrance of zinc ions within cells.
Historically Pseudomonas aeruginosa, the leading cause of morbidity and mortality in Cystic Fibrosis (CF) patients, has been the focus of intensive research to understand how this organism acquires iron in the tissues of the host17. These studies have revealed that the sputum from most CF patients chronically infected by P. aeruginosa contains high levels of the siderophores pyoverdine and pyochelin, suggesting that these iron-binding molecules have a crucial role in the recruitment of iron during infections. Moreover, the pathways for heme-iron and ferrous ions uptake are active during lung infections18, underscoring the relevance of an adequate iron supply for the ability of P. aeruginosa to colonize this tissue. Quite surprisingly very few studies have explored the relevance of zinc import systems for this microorganism. This is a significant gap in knowledge if we consider that zinc-dependent enzymes are known to contribute to antibiotic resistance and to different pathways modulating P. aeruginosa pathogenicity. For example, the arsenal of P. aeruginosa secreted virulence factors include several proteases which use zinc as cofactor19-22 and evidence has been provided for a critical role of zinc in their maturation and activation20 .
Nevertheless, a few sparse literature observations support the hypothesis that the mechanisms of zinc uptake play an important role also in P. aeruginosa. For example, a study aimed at a large scale isolation of P. aeruginosa virulence factors identified as a major candidate a gene whose disruption caused a more than 100-fold reduction in P. aeruginosa lethal dose in neutropenic mice23. This gene, denominated np20, encodes Zur, the general regulator of zinc uptake under zinc deficiency24. Subsequent studies have revealed that np20 is strongly induced by the respiratory mucus isolated by CF patients and, together the whole znuABC operon, is significantly up-regulated in bacteria recovered from the sputum of patients25. Moreover, CF lung disease is characterized by a massive and persistent recruitment of polymorphonuclear neutrophils in the airway lumen, leading to the release of large amounts of calprotectin (CP)26, 27. Recent studies have established that CP controls microbial growth by sequestrating zinc and manganese ions at sites of infection and that the ability of several pathogens to withstand the antimicrobial activity of CP relies on their ability to produce metal transporters characterized by high affinity for zinc or manganese15, 28-30. The observation that CP is one of the most abundant components of the sputum proteome from CF patients, suggest that the extraordinary ability of P. aeruginosa to colonize the inflamed CF lung must be supported by effective strategies to counteract CP-induced metal starvation.
To shed some light on the possible contribution of the Zn import apparatus to the ability of P. aeruginosa to colonize the lung of CF patients, we have undertaken a characterization of a mutant strain unable to express a functional ZnuABC importer. Our results reveal that ZnuABC is critical for the expression of different virulence features of this pathogen and suggest that other high affinity zinc import systems contribute to zinc homeostasis in P. aeruginosa.
Experimental
Reagents
Antibiotics, bovine serum albumin, 2-nitrophenyl β-D-galactopyranoside (ONPG), ethylendiaminetetraacetic acid disodium salt (EDTA), FeSO4, ZnSO4, CuSO4, MnCl2 trichloroacetic acid, azocasein, elastin congo-red, hide-remazol brilliant blue R, N-p-Tosyl-Gly-Pro-Lys 4-nitroanilide acetate salt, alginic acid from brown algae and carbazole were purchased from Sigma Aldrich. Ammonium metavanadate was purchased from Acros Organics™. Restriction endonucleases and T4 DNA ligase were purchased from New England Biolabs. High fidelity DNA polymerase Expand was obtained from Roche Diagnostics, GmbH (Mannheim, Germany). All other chemicals were purchased from VWR International. The oligonucleotides were synthesized by Primm (Milan, Italy).
Bacterial strains, plasmids and growth media
The strains, plasmids and primers used in this study are listed in Table 1. Escherichia coli and P. aeruginosa were routinely grown at 37°C in Luria-Bertani (LB) broth (10 g Bacto tryptone per liter, 5 g yeast extract per liter, 10 g NaCl per liter) eventually solidified by the addition of 1.5% (w/v) agar. Staphylococcus aureus SH100031 was grown at 37°C in brain heart infusion (BHI) broth and agar (Becton Dickinson). P. aeruginosa was grown under zinc limiting conditions in Vogel-Bonner minimal-medium E (VB-MM: 0.04 g anhydrous MgSO4 per liter, 2 g citric acid per liter, 10 g anhydrous K2HPO4 per liter, 3.5 g NaNH4HPO4-4H2O per liter, 2 g glucose per liter)32. To avoid zinc contamination from glassware, minimal media were prepared in disposable plastic containers and sterilized by filtration in Vacuum Filter-Storage Bottle Systems, 0.22 μm (Corning). Before use, the quality of each minimal medium batch was verified by monitoring the accumulation of ZnuA in Salmonella Typhimurium SA140 strain, which is abolished by zinc concentrations below 1 μM9.
TABLE 1.
Bacterial strains, plasmids and primers used
| Strain, plasmid or primer | Genotype or description | Reference(s) or source |
|---|---|---|
| E. coli | ||
| DH5α | φ80 Δ lacZ 15Δ(lac-argF) U169 deoR recA1 endA1 hsdR17 (rk-, mk+) phoA supE44 λ- thi-1 gyrA96 relA1 | Lab collection |
| HB101 | F- mcrB mrr hsdS20(rB- mB-) recA13 leuB6 ara-14 proA2 lacY1 galK2 xyl-5 mtl-1 rpsL20(SmR) glnV44 λ- | Lab collection |
| P. aeruginosa | ||
| PA14 | Wild type strain | He et al.73 |
| MDO101 | PA14 znuA:gm | This study |
| MDO102 | MDO101 znuA:scar | This study |
| S. aureus | ||
| SH1000 | Functional rsbU derivative of 8325-4 rsbU+ | Horsburgh et al.31 |
| Plasmids | ||
| pUC18 | Lab collection | |
| pEX18Tc | Broad-host-range gene replacement vector with MCS from pUC18; sacB+;TcR,oriT+ | Hoang et al. 33 |
| pRK2013 | Broad-host-range helper vector; ColE1-Tra(RK2)+,kanR | Figurski, & Helinski,34 |
| PaKOznuApEX18Tc | This study | |
| pTZ110 | Schweizer & Chuanchue, 36 | |
| ZnuApTZ110 | This study | |
| PROMznuApTZ110 | This study | |
| pPS856 | ApR, GmR | Hoang et al.33 |
| pFLP2 | Bhr Flp recombinase-producing plasmid | Hoang et al.33 |
| Primersa | ||
| PAO4(A) | CGGAATTCCCTCGTGGACTTTCTCGAGG | |
| PAO4(B) | CATAAGCTTCCTCGTGGACTTTCTCGAGG | |
| PAO5 | CGGGATCCGTGTTCGCGGTATCCGCGGT | |
| PAO6 | CGGGATCCGCAGCAGTACGTCCGGCT | |
| PAO7(B) | CATAAGCTTTCGCTCAGCACTGCCTGGC | |
| 5′-PROMPAO1 | TTTAAGCTTGCGCGGCGGCCGTCGGTTT | |
| 3′-PROMPAO1 (A) | TTTGGATCCGGCGGCACTCACATGAAAGGT | |
| 5′ZnuA | CCCGGATCCCAGCGGCTTGTGGCTCTG | |
| 3′ZnuA | CCCGAGCTCGCGTCTGTCTTGGCCATCC |
Restriction sites are underlined
Pseudomonas isolation agar (PIA; Difco) plates were used to select exconjugants when pEX18Tc29 was used as a suicide vector.
Media were supplemented with antibiotics for marker selection or plasmid maintenance as follows. For E. coli, we used 50 μg/ml kanamycin, 10 μg/ml gentamicin, 10 μg/ml tetracycline and 100 μg/ml carbenicillin. For P. aeruginosa we used 100 μg/ml gentamicin, 100 μg/ml tetracycline and 500 μg/ml carbenicillin.
Mutant strains construction
Deletion of the znuA gene was obtained by the gene replacement method described by Hoang et al.33. Two DNA fragments, flanking and entering into the znuA gene, were PCR-amplified using PA14 strain chromosomal DNA as a template and subsequently ligated to generate a DNA region encompassing the znuA gene, but lacking a 517 bp fragment of the coding sequence. The primers used to amplify the upstream fragment were PAO4(A), containing an EcoRI restriction site at its 5' end, and PAO5, containing a BamHI restriction site at its 5' end. This 800 bp fragment (denominated NT) includes at its 3’ 264 nucleotides encoding the C-terminus of ZnuA. The primers used to amplify the second DNA fragment were PAO6, containing a BamHI site at its 5' end, and PAO7(B), containing a HindIII site at its 5' end. This 800 bp DNA fragment (denominated CT) starts 641 nucleotides upstream the start codon of the znuA gene.
The NT and CT DNA fragments was digested with the appropriate restriction enzymes, ligated and inserted into the EcoRI and HindIII sites of plasmid pUC18. Then, the 830 bp FRT-aacC1-FRT cassette from plasmid pPS856 (Hoang et al., 1998), which contains the gene that confers resistance to gentamicin (aacC1, gentamicin acetyltransferase 3-1 gene) flanked by the Flp recombinase target (FRT) sequences, was inserted in the BamHI site between the NT and CT cloned fragments. The 2.43 Kb DNA fragment comprising the NT fragment, the aacC1 gene and the CT fragment was amplified using primers PAO4(B) and PAO7(B), digested with HindIII and inserted into the compatible sites of the gene replacement vector pEX18Tc33. The final construct, denominated PaKOznuApEX18Tc, was mobilized from E. coli DH5-α to P. aeruginosa strains via pRK2013-mediated triparental mating34, 35. Transconjugants were plated onto Pseudomonas isolation agar plates containing 100 μg/ml of gentamicin to select for single-crossover events in P. aeruginosa. GmR-transconjugants were streaked for isolated colonies on LB-agar plates containing 100 μg/ml of gentamicin and 5% sucrose to select for the loss of the vector sequence33.
To remove the gentamicin resistance marker, plasmid pFLP233, which contains the Flp recombinase, was transferred from E. coli to P. aeruginosa. Colonies were grown on Pseudomonas isolation agar plates containing carbenicillin (500 μg/ml) to select for pFLP2-containing P. aeruginosa. Then gentamicin-sensitive colonies were isolated and plated on LB agar containing 5% sucrose to select strains lacking the pFLP2 plasmid. The deletion of the gene of interest and the loss of FRT-aacC1-FRT cassette was confirmed by PCR and Southern blot analyses. The znuA deletion mutants with or without the gentamicin resistance cassette were referred to as MDO101 and MDO102, respectively. Most of the experiments described in this paper were carried out either with MDO101 or MDO102, obtaining essentially identical results.
To carry out complementation assays, the znuA gene was amplified by PCR using the oligonucleotides 5’znuA and 3’znuA (see Table 1) and the so obtained DNA fragment was inserted into the BamHI amd SacI restriction sites of pTZ110. The resulting plasmid, ZnuApTZ110, was introduced into MDO101 and MDO102.
Analyses of bacterial growth under low zinc availability
Bacterial cultures grown overnight in VB-MM at 37°C with shaking were diluted 1:1000 in the same medium supplemented or not with 5 μM ZnSO4. Aliquots of 200 μl of these dilutions were inoculated in a 96-well plate (Becton-Dickinson) and incubated at 37°C with shaking. Bacterial growth was monitored at 595 nm every hour for 12 hours by a microtiter-plate reader (Sunrise™ Tecan). Assays were performed in triplicate and each strain was tested in at least three independent experiments. Bacterial growth was analyzed also on VB-MM-agar plates. Overnight cultures grown in Luria-Bertani broth (LB) were normalized to an optical density at 600 nm of 1.0. Bacterial suspensions were serially diluted 1:10 and 5 μl of each dilution were plates on VB-MM-agar plate, supplemented or not with appropriate concentration of metals and/or chelating agent EDTA.
Construction of znuA-lacZ fusion and β-galactosidase activity assay
A 290 bp DNA fragment located upstream of the znuA coding sequence was amplified by PCR using the oligonucleotides 5’-PromPAO1 and 3’-PromPAO1(A) (Table 1) and PA14 chromosomal DNA as template. The obtained DNA fragment was digested with the restriction enzymes BamHI and HindIII and inserted upstream of a promoterless lacZ gene into the promoter probe plasmid pTZ11036 obtaining PROMznuApTZ110. The fusion was subsequently transferred to the wild-type and mutant strains by triparental mating34. The positive clones for the acquisition of the fusion were selected on selective medium for Pseudomonas (PIA) containing the antibiotic carbenicillin and β-galactosidase activity was measured by standard procedures37.
Inductively Coupled Plasma Mass Spectrometry (ICP-MS) analysis
Wild type PA14 and MD101 strains were grown at 37°C in standard Vogel-Bonner minimal medium or in the same medium supplemented with 3 μM ZnSO4 for 18 hours at 37°C in 50 ml polypropylene tubes. Aliquots of 2 mL of cell cultures were collected, centrifuged at 18000×g for 5 minutes and then the pellet was washed with 2 ml of phosphate buffer saline (PBS) containing 1 mM EDTA to remove excess zinc.
The periplasmic fractions were obtained by resuspending bacterial pellets in 2 ml of 20% sucrose, 30 mM Tris-HCl pH 8.0, 1 mM EDTA and 1 mg/ml lysozyme. After a 10 minutes incubation on ice, cells were centrifuged for 5 min at 18000xg and the supernatants, containing the periplasmic fractions, were removed. Pellets corresponding to the whole cells were freeze dried by using a Modulyo freeze-dryer (ThermoSavant, USA) and weighted by an AX26 DeltaRange™ balance (Mettler-Toledo, Greifensee, Switzerland). Acid digestion of samples and ICP-MS analysis was carried out essentially as previously described38, 39 Method sensitivity, repeatability, and trueness were assessed by calculating the limits of detection, limits of quantification, coefficients of variation, and the recovery functions, respectively, for each analysed elements38. The periplasmic fractions were diluted tenfold with 1% HNO3 and analyzed by applying the standard addition method as described in a previous study38.
The significance of the differences between the measured element concentrations was evaluated by a two factor ANOVA performed with cell strain and zinc concentration in cell media as the independent factors. Fisher post hoc test was used to perform pairwise multiple comparisons. p values less than 0.05 were considered statistically significant. Statistical analysis was performed with Statistica 6.0 (StatSoft Inc., Tulsa, OK) software.
Calprotectin resistance assay
Overnight cultures of P. aeruginosa were diluted 1:50 in LB added back and incubated with shaking for an additional 1 hour at 37 °C. For the CP inhibition assay, growth conditions consisted of 60 percent LB and 40 percent CP buffer (20 mM Tris-HCl, pH 7.5, 100 mM NaCl, 5 mM β-mercaptoethanol, 3 mM CaCl2) ratio plus increasing concentrations of CP (0-1000 μg/mL). PA14 wild type or the PA14 znuA mutant strains were diluted 1:100 and incubated at 37 °C with shaking. Growth was monitored at 2 hour intervals throughout the time course. Bacterial growth in the presence of CP was normalized to growth without CP from data obtained after 8 hours. Statistical significance was determined by Student's t test with a p < 0.05 being considered significant.
Protease assays
To obtain culture supernatants, 6.0 ml of culture medium (LB or VB-MM) were inoculated with bacteria and incubated overnight at 37 °C with shaking. Then, samples were centrifuged twice at 13000 × g for 15 minutes at 4 °C, and the supernatants were stored at −20 °C.
Total proteolytic activity was determined using azocasein as substrate, using a procedure previously described20, 40 with minor modifications. Briefly, 0.1 ml of each culture supernatant was added to 0.9 ml of 10 mM Tris-HCl, pH 8.0 containing 5 mg of azocasein, and the reaction mixture was incubated at 37 °C for 30 minutes. The undigested substrate was precipitated by adding trichloroacetic acid (3.3%) to each reaction tube and removed by centrifugation (13000 × g, 20 minutes). The absorbance at 415 nm was measured by a microtiter-plate reader (Sunrise™ Tecan).
Elastolytic activity in culture supernatants was quantified by using insoluble elastin Congo red as substrate, as described20, 41. 0.1 ml of each supernatant was added to 0.4 ml of 10 mM Tris-HCl, pH 8.0 containing 5 mg of substrate. The mixture of reaction was incubated at 37 °C under shaking. After 24 hours, undigested elastin was removed by centrifugation at 13000 × g for 10 minutes and the absorbance at 492 nm measured using a microtiter-plate reader (Sunrise™ Tecan).
Staphylolytic activity of supernatant samples of P. aeruginosa strains was determined by monitoring the decrease in absorbance at 595 nm of a heat-killed Staphylococcus aureus suspension42, 43. S. aureus strain SH100031 was cultured in BHI broth overnight at 37 °C with shaking. Bacteria were pelleted by centrifugation, resuspended in 20 mM Tris-HCl, pH 8.8 to a final optical density at 595 nm of 1.0, and killed at 100 °C for 30 minutes. Aliquots (0.1 ml) of supernatants were added to 0.9 ml of heat-killed bacteria suspension. Staphylolytic activity was determined by measuring the change in absorbance at 595 nm every 15 minutes for 3 hours by using a microtiter-plate reader (Sunrise™ Tecan).
Protease IV activity was measured using the chromogenic peptide Chromozym PL (tosyl-Gly-Pro.Lys-p-nitroanilide) as substrate43, 44. The supernatant (0.1 ml) was added to 0.4 ml of reaction mixture (50 mM Tris-HCl, pH 8.0, 150 mM NaCl mixed with 40 μg of Chromozym PL). The reactions were incubated at 37 °C for 30 minutes and then read in a microtiter plate at 415 nm using a Sunrise™ Tecan plate reader.
The activity of alkaline protease was determined using Hide powder azur. The supernatant (0.1 ml) was added to 0.4 ml of 20 mM Tris-HCl, pH 8.0 containing 5 mg of substrate. Samples were incubated at 37 °C for 1 hour in a shaking incubator, centrifuged at 13000 × g for 10 minutes, and the absorbance at 595 nm was then determined.
Student's t-test was used to determine the significance of differences.
Alginate production determination
P. aeruginosa strains were grown at 30 °C for 48 hours on PIA plates supplemented or not with ammonium metavanadate (PIA-AMV) plates45. All biological material was recovered from the surface of each PIA-AMV plate and suspended in 25 ml of PBS. The optical density at 600 nm of the bacterial suspension in PBS was measured and adjusted. The bacterial suspensions were spun at 1300 rpm to pellet bacterial cells and the supernatant fractions were recovered. Levels of alginate were assayed using the carbazole assay described by Knutson and Jeanes46 with minor modifications. The supernatant (0.1 ml) was mixed with 2.5 ml of borate-sulfuric acid reagent (10 mM H3BO3 in concentrated H2SO4) and 75 μl of carbazole reagent (0.1% in ethanol). The reaction was then incubated at 55 °C for 30 minutes, and the absorbance at 530 nm was measured spectrophotometrically. The alginate concentration was quantified using a standard curve of Macrocystis pyrifera alginate (0 to 60 μg/ml). Statistical significance was determined by Student's t test.
Mouse infection studies
For animal studies we used C57Bl/6 or CD1 male mice (Charles River). Mice were acclimatized for a minimum of 1 week before use. Mice were housed in sterile ventilated cages in a humidity (40-60%) and temperature (20-22°C) controlled environment, with a 12 hours light/dark cycle (lights on at 7 AM). P. aeruginosa strains (wild type PA14 and MDO101) were cultured in VB-MM to exponential phase (optical density at 600 nm approx. 0.5) and diluted in sterile PBS at the appropriate concentration.
For mouse competition assays, we carried out a first experiment with animals of 8 weeks of age and a second one with animals of 12 weeks of age, obtaining essentially the same results. Groups of 6 animals were inoculated intraperitoneally with 0.2 ml of PBS containing 2 × 106 colony forming units (cfu) and sacrificed after 18 hours. Bacteria were recovered from spleen and lung, plated for single colonies, and 200 colonies were picked on selective PIA plates containing 100 μg/ml of gentamicin. The competitive index (CI) was calculated using the formula CI = output (strain A/strain B)/input (strain A/strain B).
For acute lung infections, PA14 and MDO101 strains were grown to exponential phase in VB-MM, pelleted by centrifugation (2700 × g, 15 minutes), washed twice with sterile PBS, and appropriate dilutions in sterile PBS were prepared. Mice were anesthetized with 2.5% avertin (2,2,2-tribromethanol, 97%; Sigma Aldrich) in 0.9% NaCl, intubated with a 22-gauge venous catheter and inoculated with 5×106 cfu into both lung lobes. After infection, mortality and body weight were monitored for one week. Statistical analysis was performed using Fisher's exact test (two tailed) for categorical variables.
Ethics Statement
Animal studies performed either at the Italian Istituto Superiore di Sanità (ISS) or at the San Raffaele Scientific Institute (Milan, Italy) were carried out according to the Italian Ministry of Health guidelines for the use and care of experimental animals All experiments were previously approved by the local Ethical Committee and carried out under the supervision of certified veterinarians.
Results
Analysis of the contribution of ZnuA to P. aeruginosa growth in zinc poor media
We have analyzed bacterial growth in a chemically defined medium (VB-MM) containing only contaminant traces of zinc38. Unlike other bacterial strains tested under similar conditions9, 47 the P. aeruginosa znuA mutant strain showed only a marginal growth defect with respect to the wild type strain (Figure 1A). A more marked zinc-dependent growth defect was observed in VB-MM agar plates in the presence of 10 μM EDTA (Figure 1B). All these growth defects were complemented by a plasmid containing the znuA gene (data not shown). We have also tested the ability of CP to inhibit P. aeruginosa growth. Figure 2 shows that incubation of bacteria with 1000 μg/ml of purified CP caused a 75% growth inhibition of the wild type strain and a 85% growth inhibition of the znuA strain. Although the difference between the two strains is statistically significant, it should be noted that the concentration of CP used in this assay is able to completely inhibit growth of other bacteria such A. baumannii48 and S. Typhimurium30.
Figure 1. Growth of P. aeruginosa in chemically defined VB-MM.
A) Wild type (squares) and znuA (circles) P. aeruginosa PA14 strains were grown in standard VB-MM (filled symbols) or in the same medium supplemented with 5 μM ZnSO4 (open symbols). B) Wild type and znuA P. aeruginosa PA14 strains were grown in VB-MM agar plates, in VB-MM agar plates supplemented with 10 μM EDTA or in VB-MM agar plates supplemented with 10 μM EDTA and 10 μM ZnSO4 .
Figure 2. CP_mediated inhibition of P. aeruginosa growth in vitro.

Growth of wild type and znuA PA14 strains in the presence of 1 mg/ml CP with respect to untreated controls. Data represent the average ± SD of nine replicates. * p < 0.05.
ZnuA expression as a function of zinc availability
To gain information on the involvement of ZnuABC in the response of P. aeruginosa to zinc paucity, we have analyzed the expression of znuA using a transcriptional fusion between the znuA promoter and the lacZ reporter gene. The results reported in Figure 3A and 3C show that znuA expression is higher in VB-MM than in LB medium and is induced by chelating agents and repressed by zinc. Moreover, β-galactosidase expression from the reporter plasmid in response to EDTA is higher when measured in the znuA mutant strain than in wild type PA14 (Figure 3B and 3D), indicating that the absence of ZnuA subtly modifies intracellular zinc availability. Although this picture is coherent with the idea that the ZnuABC is under control of Zur and is induced under conditions of zinc deficiency, it should be noted that the znuA mutant strain shows a significant basal level of expression either in LB medium or in VB-MM supplemented with zinc. This finding contrasts with previous studies on other bacteria showing that micromolar zinc concentrations nearly abolish znuA expression in other bacteria9, 10, 47. We hypothesize that a constitutive basal level of znuABC expression could be the consequence of the specific gene arrangement of the znuABC operon in P. aeruginosa. In fact, whereas in other bacteria the zur gene and znuABC are located in separated chromosomal locations, P. aeruginosa is characterized by the insertion of np20 (zur) between the divergently transcribed znuA and znuC genes (see Supplementary Figure 1).
Figure 3. znuA expression in P. aeruginosa PA14.
A) Expression of znuA in LB medium. Wild type PA14 carrying plasmid PROMznuApTZ110 was grown overnight in LB medium, LB containing 0.5 mM EDTA or LB containing 0.5 mM EDTA and 0.5 mM ZnSO4 and β-galactosidase activity was determined as described in the Experimental section. B) Differences in znuA expression in wild type and znuA mutant (MD101) strains in LB supplemented with 0.5mM EDTA. C) Expression of znuA in VB-MM medium. Wild type PA14 carrying plasmid PROMznuApTZ110 was grown overnight in VB-MM in the presence or absence of 10 μM zinc and EDTA supplementation. D) Differences in znuA expression in wild type and znuA mutant (MD101) strains in VB-MM supplemented with 10 μM EDTA. * p < 0.05, ** p < 0.01.
Elemental profile of wild type and mutant P. aeruginosa strains
Previous studies have shown that inactivation of znuA in Salmonella causes marked modifications in the intracellular concentration of various metal ions 38. To gain further insight into the role of ZnuA in metal homeostasis in P. aeruginosa, we have measured the intracellular content of several metal ions in wild type and znuA mutant strains grown in VB-MM, in the presence or absence of zinc supplementation, by ICP-MS. We found that wild type and znuA mutant strains show remarkable differences in their ionomic profiles either when cultivated in zinc-free VB-MM or in the zinc-replete medium (supplementary Figure 2 and supplementary Table 1). The mutant strain accumulated higher levels of Cu, Co, Cr and Rb and a lower amount of Mn in the Zn-depleted medium. Most of these differences were abrogated in the zinc-containing medium, where, however, the mutant strain exhibited a higher content of Mg and K. Both the wild type and znuA strains showed a marked decrease in Mn and Ni content when cultivated in presence of zinc, a behavior which is suggestive of zinc-mediated inhibition of metal specific importers49, 50. In contrast, Sr uptake was enhanced in presence of zinc. Quite unexpectedly, the znuA mutant strain contained less Mn than the wild type strain when cultivated in standard VB-MM. This observation, which deserves further investigations, suggests that ZnuABC could have an important role in manganese uptake in P. aeruginosa. No significant differences were found for Fe and other metals such as Ca, Na, and Al (not shown). As far as intracellular zinc content is concerned, the znuA mutant contained the same amount of zinc as the wild type strain when cultivated in minimal medium (Figure 4A), further supporting the hypothesis that other uptake systems may compensate for the absence of a functional ZnuABC transporter. For both strains there was a statistically significant increase in zinc content in the zinc rich medium. The analysis of the metal content of cytoplasmic (spheroplasts) and periplasmic fractions (Figure 4B and C) suggests that the intracellular zinc content is modestly affected by the presence or absence of ZnuA and by the extracellular concentration of the metal, whereas the periplasmic zinc concentration varies as a function of zinc concentration in the medium. This observation suggests that P. aeruginosa is able to control the cytoplasmic concentration of zinc in environmental conditions characterized by an excess of the metal, while the periplasmic environment reflects the concentration of the metal present in the medium.
Figure 4. Zinc content of wild type and znuA PA14 strains grown in VB-MM and VB-MM supplemented with 3 μM ZnSO4.

A) Total zinc content determined on bacterial pellets as recovered from overnight cultures in VB-MM. B) Zinc content in bacterial spheroplasts, obtained after removal of the periplasmic fractions. C) Zinc concentration in periplasmic fractions. Data are mean concentrations obtained from 4 independent bacterial cultures and bars indicate mean standard deviations. * p < 0.05.
ZnuA is required for efficient alginate production
Recent studies have shown that PA14 develops a mucoid phenotype when cultivated in PIA plates supplemented with ammonium metavanadate45, 51, a condition that likely induces cell surface stress and activation of the alginate synthetic pathway52. In line with the above mentioned studies, we have observed that wild type PA14 does not show a mucoid phenotype when plated on standard PIA agar plates, but overproduces alginate in the presence of ammonium metavanadate (Supplementary Figure 3). In contrast, we observed that the znuA mutant strain is unable to produce high levels of alginate under the same conditions. A quantitative evaluation of alginate production through the carbazole assay, revealed that the znuA mutation halves the ability of P. aeruginosa PA14 to produce this exopolysaccharide in response to ammonium metavanadate (Figure 5).
Figure 5. Alginate production in wild type and znuA PA14 strains. The level of alginate produced by wild type and znuA PA14 strains grown in PIA agar plates supplemented with ammonium vanadate was measured by the carbazole assay.

Data are means ± SD of four independent experiments. * p < 0.05.
Disruption of the znuA gene affects extracellular proteases activity
To evaluate the possibility that alterations in zinc homeostasis due to znuA inactivation might affect the release of P. aeruginosa virulence factors, we measured total extracellular protease activity as well as the specific activity of four distinct zinc-containing proteases, i.e. LasA, LasB, protease IV and alkaline protease.
Deletion of znuA caused a noteworthy decrease of total extracellular protease activity either in bacteria cultivated in LB medium or in VB-MM (Figure 6, panels A and B). The addition of zinc to VB-MM led to a 4 fold increase of total proteolytic activity, highlighting the importance of this metal for the production of active proteases. A comparable behavior was also observed for LasA, LasB and protease IV, whose activity was decreased in the znuA strain cultivated in VB-MM and, in the case of protease IV, also in LB medium (Supplementary Figure 4). Although the activity of all these proteases increased in bacteria cultivated in VB-MM supplemented with zinc, it should be noted that in most cases the addition of zinc is not sufficient to equalize the activity in the two strains. This observation suggests that ZnuA is also necessary for correct zinc homeostasis in zinc replete environments.
Figure 6. Effect of znuA mutation on extracellular protease activity.
A) Total protease activity in the supernatants from wild type and znuA PA14 strains grown in LB medium. B) Total protease activity in the supernatants from bacteria grown in VB-MM or in VB-MM supplemented with 10 μM zinc. C) LasA, D) LasB, E) Protease IV, F) Alkaline protease activity in the supernatants from bacteria grown overnight in VB-MM or in VB-MM supplemented with 10 μM zinc. Data are means ± SD of at last three independent experiments. * p < 0.05, ** p < 0.01.
An exception to this general model is represented by alkaline protease, whose activity is not affected in the znuA mutant strain (Figure 6 and Supplementary Figure 4)
Mice infections
To analyze the role of ZnuA in zinc uptake in vivo, we have initially carried out competition assays in C57Bl/6 mice infected intraperitoneally. The znuA mutant proved to be significantly disadvantaged with respect to the wild type strain (Figure 7). However, it should be noted that high numbers of znuA cells were recovered from tissues, indicating that both the wild type and the znuA mutant strains have high ability to proliferate in the infected host. This observation is in contrast to studies carried out with other bacteria that have shown that the wild-type strain largely outcompetes the znuA mutant strain during infections10. Similar results were obtained in CD1 mice (data not shown).
Figure 7. Competition assay in intraperitoneally infected mice.

Bacteria were recovered from the spleens and lungs of C57Bl/6 mice infected with mixed inocula (wild type vs znuA) and enumerated in agar plates. * p < 0.05, ** p < 0.01
In line with the idea that znuA disruption has a minor effect on P. aeruginosa virulence, we were not able to observe significant differences in the mortality induced by the wild type and the znuA PA14 strains in lung infected C57Bl/6 mice (Supplementary Figure 4)
Discussion
The pathways enabling bacteria to recruit transition metals within the infected host are key to bacterial survival and attractive candidates for the development of novel anti-infective treatments. For example, based on the observation that gallium interferes with iron metabolism in P. aeruginosa it has been proposed that gallium-based treatments could be used to eradicate this pathogen from CF patients53. Whereas some studies have clearly indicated that zinc promotes P. aeruginosa virulence20, 54, only a handful of studies have directly addressed the importance of zinc uptake for the ability of this pathogen to cause disease. As a first step to evaluate the role of zinc importers in P. aeruginosa pathogenicity we have carried out a characterization of a PA14 strain lacking a functional ZnuABC transporter.
It has been recently shown that PAO1 mutant strain lacking the genes encoding for ZnuA, ZnuC or ZnuB have a slightly reduced ability to grow in LB medium supplemented with 0.5 mM EDTA55. As bacterial responses to chelating agents are sometimes ambiguous56, we analyzed growth of a PA14 mutant strain lacking znuA in a chemically defined minimal medium containing only contaminant traces of zinc. In line with the results of Ellison et al55, the mutant strain exhibited a modest growth defect (Figure 1A) and a more marked phenotype could be observed only in minimal medium agar plates supplemented with EDTA (Figure 1b), a result possibly favored by the ability of the solid agar support to limit zinc availability to bacteria57. The small impact of znuA deletion on bacterial growth is accompanied by the substantial equality of the intracellular zinc content between the wild-type and the mutant strains grown in minimal medium (Figure 4). However, it should be noted that ICP-MS analyses provide information on the total amount of zinc present in cells, but cannot distinguish between the zinc tightly bound to macromolecules and the small quota of labile metal which regulates transcription from Zur-regulated genes. Instead, an analysis of znuA transcription from a reporter plasmid (Figure 3, panels B and D) suggests that the strain lacking ZnuA contains a reduced pool of free zinc. At the same time, significant differences were detected in the global ionomic profiles of wild type and znuA mutant PA14 strains (supplementary Figure 2 and Supplementary Table 1), suggesting that small alterations in zinc homeostasis may significantly affect the metal content of the bacterial cell.
These observations suggest that P. aeruginosa continues to import the zinc necessary for its growth also in the absence of a functional ZnuABC importer. This conclusion is also supported by the remarkable ability of P. aeruginosa to grow in the presence of high concentrations of CP (Figure 2). CP concentration in the sputum of CF patients correlates with zinc levels58. Both CP and zinc levels decrease following treatment of CF exacerbations, suggesting that most of the zinc present in lung secretion could be tightly bound to CP. These observations support the hypothesis that CP is abundantly released in the airway secretions in an effort to contain bacterial proliferation, but that the ability of P. aeruginosa to colonize the CF lung is based on the ability to withstand the host mechanisms of zinc sequestration.
The capability of P. aeruginosa to grow efficiently without a functional znuA gene or in the presence of high amounts of CP is suggestive of the existence of additional high affinity zinc importers. Recent studies have in fact revealed that some pathogens possess more than one mechanism to acquire zinc from the environment. For example, Listeria monocytogenes expresses two ABC-type zinc importers (ZnuABC and ZurAM), both contributing to virulence, but individually able to ensure efficient growth in a chemically defined media59. Redundant zinc import systems have been identified in other bacteria able to colonize the airways, such as N. meningitidis, A. baumannii and Y. pestis. Under conditions of zinc deficiency, all these bacteria produce membrane proteins that facilitate zinc import. In particular, it has been recently shown that the siderophore yersiniabactin may function as a zincophore in Y. pestis, thus mediating zinc uptake through a inner membrane receptor specifically recognizing the zinc-yersinabactin complex13. Although previous studies have suggested the existence of other zinc importers in P. aeruginosa55, 60, the identity of the other transporter(s) ensuring efficient zinc uptake in the absence of a functional ZnuABC importer is still to be determined.
Interestingly, although inactivation of znuA is accompanied by limited growth defects, we found that different virulence-related features are altered in the absence of a functional ZnuABC transporter. We have shown that the absence of znuA affects the capability of P. aeruginosa to produce the exopolysaccharide alginate in response to stress induced by ammonium metavanadate in PIA agar plates (Figure 5 and supplementary Figure 3). Alginate forms a capsule that protects P. aeruginosa from phagocytosis, antibiotics and a variety of host antimicrobial factors61-63. Moreover, alginate production is favored by anaerobic conditions and this contributes to persistence and to chronic P. aeruginosa infections in the lung of CF patients64, 65. Alginate production is negatively regulated by the anti-sigma factor MucA61. Alginate-overproducing mucoid strains of P. aeruginosa are generally characterized by mutations in mucA, whereas non-mucoid strains can induce production of the exopolysaccharide through a finely regulated pathway leading to the proteolytic inactivation of MucA. This pathway involves zinc-containing proteases, such as MucP and ClpX61. Based on this, our data suggest that the decreased ability of the znuA mutant to secrete alginate could be explained by alterations in the expression and/or maturation of zinc-depending enzymes.
This possibility is also supported by the data showing that zinc availability promotes secretion of active extracellular proteases and that the supernatants from cultures of the znuA mutant strain contain lower protease activity than those from the wild type strain (Figure 6). In particular, our data demonstrate that the activity of three distinct zinc-containing extracellular proteases, LasA, LasB and protease IV, is decreased in the mutant strain. An exception to this trend is represented by alkaline protease, whose activity is significantly induced by zinc addition to the minimal medium (Figure 6E), but is very similar in the wild type and mutant strains. Whereas, in P. aeruginosa most proteases are secreted through the general secretion pathway and mature in the periplasmic compartment21, alkaline protease is exported through an independent secretory pathway resembling the type I secretion system66, 67. Little is known about the mechanisms of zinc incorporation in P. aeruginosa proteases, but our data suggest that alkaline protease may acquire zinc in a distinct cellular compartment with respect to the other proteases. Proteins secreted via the general secretory pathways usually incorporate the metal in the periplasmic compartment68, whereas proteins secreted by the type I secretion system bypass the periplasm and mature in the extracellular milieu69. It is worth noting that, although the difference does not reach statistical significance, the periplasmic fraction from the znuA strain contains a lower amount of zinc compared to that from the wild type strain (figure 4C). This observation supports the hypothesis that the absence of ZnuA subtly modulates zinc distribution in the cell. Another possibility consistent with such observations is that ZnuA, in addition to its well-known role in the transport of zinc, could play a role as a chaperone facilitating zinc acquisition by periplasmic zinc proteins. This possibility could explain the observation that znuA is significantly expressed in bacteria growing in LB or in media supplemented with zinc (Figure 3) and that the total extracellular protease activity (Figure 6A) and the activity of protease IV is significantly decreased in LB. We propose that the constitutive level of expression of znuA is a consequence of the peculiar organization of the znuABC operon in P. aeruginosa (supplementary Figure 1). The arrangement of the operon is suggestive of a leaky regulation of transcription of the znuA gene to ensure the constant production of the Zur regulator that is needed to control the expression of several other genes70-72. We actually observed that two other Zur-regulated genes (rpm2 and dksA2) are more tightly controlled than znuA under zinc replete conditions (data not shown). We suggest that the specific arrangement of the znuABC operon is indicative of a constitutive role of ZnuA which may be related to the need for maintaining a constant influx of zinc or for a role in the control of zinc distribution in the periplasmic space.
We have also carried out experiments to evaluate the consequence of znuA deletion on P. aeruginosa virulence in mice. Competition experiments in intraperitoneally infected C57Bl/6 and CD1 mice revealed that wild type PA14 colonize the spleen and the lungs more efficiently than the znuA mutant strain. However, unlike the case with other bacteria where the znuA mutant shows a dramatic loss of capability to disseminate within the host compared to wild type strain4, 10, the competitive index between the two strains is rather low and both the strains induce a comparable mortality in C57Bl/6 mice infected with a 2 × 106 CFU dose (data not shown). At the same time, preliminary acute lung infection experiments confirm that wild type and znuA PA14 strains induce comparable mortality and loss of weight (Supplementary Figure 5).
In conclusion this study reveals that inactivation of znuA affects the ability of P. aeruginosa to produce alginate and secrete extracellular proteases, thus supporting the idea that zinc acquisition is critical for full virulence of this pathogen. At the same time, however, we observed that P. aeruginosa has a remarkable resistance to the antimicrobial activity of CP and that the znuA mutant strain shows modest growth defects in Zn-limited environments, elevated intracellular Zn content and a limited reduction of virulence in mice. These observations suggest that P. aeruginosa is equipped with redundant mechanisms for the acquisition of Zn which may compensate for the absence of a functional ZnuABC transporter. We propose that the high resistance to zinc restriction may significantly contribute to colonization of the CF lung.
Supplementary Material
Acknowledgments
This work was supported by the grant FFC13-2012 (to A.B.) from the Italian Foundation for Cystic Fibrosis Research (FFC), and R01AI101171 from the National Institutes of Health and Merit Award INFB-024-13F from the Department of Veterans Affairs from the United States (to E.P.S) Special thanks are due to Alessandra Bragonzi, Ida De Fino and Alice Rossi of the CF Animal Core Facility (CFaCore) for carrying out lung infection experiments and for providing us the Pseudomonas aeruginosa PA14 and Staphylococcus aureus SH1000 strains. Thanks are due to Herbert P Schweizer for providing the plasmids used to construct the znuA mutant strains.
References
- 1.Hood MI, Skaar EP. Nature reviews. Microbiology. 2012;10:525–537. doi: 10.1038/nrmicro2836. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Andreini C, Bertini I, Rosato A. Accounts of chemical research. 2009;42:1471–1479. doi: 10.1021/ar900015x. [DOI] [PubMed] [Google Scholar]
- 3.Andreini C, Banci L, Bertini I, Rosato A. Journal of proteome research. 2006;5:3173–3178. doi: 10.1021/pr0603699. [DOI] [PubMed] [Google Scholar]
- 4.Cerasi M, Ammendola S, Battistoni A. Frontiers in cellular and infection microbiology. 2013;3:108. doi: 10.3389/fcimb.2013.00108. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Patzer SI, Hantke K. Molecular microbiology. 1998;28:1199–1210. doi: 10.1046/j.1365-2958.1998.00883.x. [DOI] [PubMed] [Google Scholar]
- 6.Outten CE, Tobin DA, Penner-Hahn JE, O'Halloran TV. Biochemistry. 2001;40:10417–10423. doi: 10.1021/bi0155448. [DOI] [PubMed] [Google Scholar]
- 7.Wang D, Hurst TK, Thompson RB, Fierke CA. Journal of biomedical optics. 2011;16:087011. doi: 10.1117/1.3613926. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Yang X, Becker T, Walters N, Pascual DW. Infection and immunity. 2006;74:3874–3879. doi: 10.1128/IAI.01957-05. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Ammendola S, Pasquali P, Pistoia C, Petrucci P, Petrarca P, Rotilio G, Battistoni A. Infection and immunity. 2007;75:5867–5876. doi: 10.1128/IAI.00559-07. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Petrarca P, Ammendola S, Pasquali P, Battistoni A. Journal of bacteriology. 2010;192:1553–1564. doi: 10.1128/JB.01310-09. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Davis LM, Kakuda T, DiRita VJ. Journal of bacteriology. 2009;191:1631–1640. doi: 10.1128/JB.01394-08. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Stork M, Bos MP, Jongerius I, de Kok N, Schilders I, Weynants VE, Poolman JT, Tommassen J. PLoS pathogens. 2010;6:e1000969. doi: 10.1371/journal.ppat.1000969. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Bobrov AG, Kirillina O, Fetherston JD, Miller MC, Burlison JA, Perry RD. Molecular microbiology. 2014;93:759–775. doi: 10.1111/mmi.12693. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Desrosiers DC, Bearden SW, Mier I, Jr., Abney J, Paulley JT, Fetherston JD, Salazar JC, Radolf JD, Perry RD. Infection and immunity. 2010;78:5163–5177. doi: 10.1128/IAI.00732-10. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Mortensen BL, Rathi S, Chazin WJ, Skaar EP. Journal of bacteriology. 2014;196:2616–2626. doi: 10.1128/JB.01650-14. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Mortensen BL, Skaar EP. Cellular microbiology. 2012;14:1336–1344. doi: 10.1111/j.1462-5822.2012.01817.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Lamont IL, Konings AF, Reid DW. Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine. 2009;22:53–60. doi: 10.1007/s10534-008-9197-9. [DOI] [PubMed] [Google Scholar]
- 18.Nguyen AT, O'Neill MJ, Watts AM, Robson CL, Lamont IL, Wilks A, Oglesby-Sherrouse AG. Journal of bacteriology. 2014;196:2265–2276. doi: 10.1128/JB.01491-14. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Kuang Z, Hao Y, Walling BE, Jeffries JL, Ohman DE, Lau GW. PloS one. 2011;6:e27091. doi: 10.1371/journal.pone.0027091. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Olson JC, Ohman DE. J Bacteriol. 1992;174:4140–4147. doi: 10.1128/jb.174.12.4140-4147.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Kessler E, Safrin M, Gustin JK, Ohman DE. The Journal of biological chemistry. 1998;273:30225.–30231. doi: 10.1074/jbc.273.46.30225. [DOI] [PubMed] [Google Scholar]
- 22.Preston MJ, Seed PC, Toder DS, Iglewski BH, Ohman DE, Gustin JK, Goldberg JB, Pier GB. Infection and immunity. 1997;65:3086–3090. doi: 10.1128/iai.65.8.3086-3090.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Wang J, Mushegian A, Lory S, Jin S. Proceedings of the National Academy of Sciences of the United States of America. 1996;93:10434–10439. doi: 10.1073/pnas.93.19.10434. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Wang J, Lory S, Ramphal R, Jin S. Molecular microbiology. 1996;22:1005–1012. doi: 10.1046/j.1365-2958.1996.01533.x. [DOI] [PubMed] [Google Scholar]
- 25.Son MS, Matthews WJ, Jr., Kang Y, Nguyen DT, Hoang TT. Infect Immun. 2007;75:5313–5324. doi: 10.1128/IAI.01807-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.MacGregor G, Gray RD, Hilliard TN, Imrie M, Boyd AC, Alton EW, Bush A, Davies JC, Innes JA, Porteous DJ, Greening AP. J Cyst Fibros. 2008;7:352–358. doi: 10.1016/j.jcf.2007.12.005. [DOI] [PubMed] [Google Scholar]
- 27.Gray RD, MacGregor G, Noble D, Imrie M, Dewar M, Boyd AC, Innes JA, Porteous DJ, Greening AP. American journal of respiratory and critical care medicine. 2008;178:444–452. doi: 10.1164/rccm.200703-409OC. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Corbin BD, Seeley EH, Raab A, Feldmann J, Miller MR, Torres VJ, Anderson KL, Dattilo BM, Dunman PM, Gerads R, Caprioli RM, Nacken W, Chazin WJ, Skaar EP. Science. 2008;319:962–965. doi: 10.1126/science.1152449. [DOI] [PubMed] [Google Scholar]
- 29.Gaddy JA, Radin JN, Loh JT, Piazuelo MB, Kehl-Fie TE, Delgado AG, Ilca FT, Peek RM, Cover TL, Chazin WJ, Skaar EP, Scott Algood HM. PLoS pathogens. 2014;10:e1004450. doi: 10.1371/journal.ppat.1004450. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Liu JZ, Jellbauer S, Poe AJ, Ton V, Pesciaroli M, Kehl-Fie TE, Restrepo NA, Hosking MP, Edwards RA, Battistoni A, Pasquali P, Lane TE, Chazin WJ, Vogl T, Roth J, Skaar EP, Raffatellu M. Cell host & microbe. 2012;11:227–239. doi: 10.1016/j.chom.2012.01.017. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Horsburgh MJ, Aish JL, White IJ, Shaw L, Lithgow JK, Foster SJ. Journal of bacteriology. 2002;184:5457–5467. doi: 10.1128/JB.184.19.5457-5467.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Vogel HJ, Bonner DM. The Journal of biological chemistry. 1956;218:97–106. [PubMed] [Google Scholar]
- 33.Hoang TT, Karkhoff-Schweizer RR, Kutchma AJ, Schweizer HP. Gene. 1998;212:77–86. doi: 10.1016/s0378-1119(98)00130-9. [DOI] [PubMed] [Google Scholar]
- 34.Figurski DH, Helinski DR. Proceedings of the National Academy of Sciences of the United States of America. 1979;76:1648–1652. doi: 10.1073/pnas.76.4.1648. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Ditta G, Stanfield S, Corbin D, Helinski DR. Proceedings of the National Academy of Sciences of the United States of America. 1980;77:7347–7351. doi: 10.1073/pnas.77.12.7347. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Schweizer HP, Chuanchuen R. BioTechniques. 2001;31:1258, 1260, 1262. doi: 10.2144/01316bm06. [DOI] [PubMed] [Google Scholar]
- 37.Miller JH. Experiments in Molecular Genetics. Cold Spring Harbor, NY: 1972. [Google Scholar]
- 38.Ciavardelli D, Ammendola S, Ronci M, Consalvo A, Marzano V, Lipoma M, Sacchetta P, Federici G, Di Ilio C, Battistoni A, Urbani A. Molecular bioSystems. 2011;7:608–619. doi: 10.1039/c0mb00140f. [DOI] [PubMed] [Google Scholar]
- 39.Ciavardelli D, D'Orazio M, Pieroni L, Consalvo A, Rossi C, Sacchetta P, Di Ilio C, Battistoni A, Urbani A. Molecular bioSystems. 2013;9:1117–1126. doi: 10.1039/c3mb25594h. [DOI] [PubMed] [Google Scholar]
- 40.Kessler E, Safrin M, Peretz M, Burstein Y. FEBS letters. 1992;299:291–293. doi: 10.1016/0014-5793(92)80134-3. [DOI] [PubMed] [Google Scholar]
- 41.Ohman DE, Cryz SJ, Iglewski BH. J Bacteriol. 1980;142:836–842. doi: 10.1128/jb.142.3.836-842.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Kessler E, Safrin M, Abrams WR, Rosenbloom J, Ohman DE. J Biol Chem. 1997;272:9884–9889. doi: 10.1074/jbc.272.15.9884. [DOI] [PubMed] [Google Scholar]
- 43.Caballero AR, Moreau JM, Engel LS, Marquart ME, Hill JM, O'Callaghan RJ. Anal Biochem. 2001;290:330–337. doi: 10.1006/abio.2001.4999. [DOI] [PubMed] [Google Scholar]
- 44.O'Callaghan RJ, Engel LS, Hobden JA, Callegan MC, Green LC, Hill JM. Investigative ophthalmology & visual science. 1996;37:534–543. [PubMed] [Google Scholar]
- 45.Damron FH, Davis MR, Jr., Withers TR, Ernst RK, Goldberg JB, Yu G, Yu HD. Molecular microbiology. 2011;81:554–570. doi: 10.1111/j.1365-2958.2011.07715.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Knutson CA, Jeanes A. Anal Biochem. 1968;24:470–481. doi: 10.1016/0003-2697(68)90154-1. [DOI] [PubMed] [Google Scholar]
- 47.Gabbianelli R, Scotti R, Ammendola S, Petrarca P, Nicolini L, Battistoni A. BMC microbiology. 2011;11:36. doi: 10.1186/1471-2180-11-36. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Hood MI, Mortensen BL, Moore JL, Zhang Y, Kehl-Fie TE, Sugitani N, Chazin WJ, Caprioli RM, Skaar EP. PLoS Pathog. 2012;8:e1003068. doi: 10.1371/journal.ppat.1003068. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.McDevitt CA, Ogunniyi AD, Valkov E, Lawrence MC, Kobe B, McEwan AG, Paton JC. PLoS Pathog. 2011;7:e1002357. doi: 10.1371/journal.ppat.1002357. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Counago RM, Ween MP, Begg SL, Bajaj M, Zuegg J, O'Mara ML, Cooper MA, McEwan AG, Paton JC, Kobe B, McDevitt CA. Nature chemical biology. 2014;10:35–41. doi: 10.1038/nchembio.1382. [DOI] [PubMed] [Google Scholar]
- 51.Damron FH, Barbier M, McKenney ES, Schurr MJ, Goldberg JB. Journal of bacteriology. 2013;195:4020–4036. doi: 10.1128/JB.00534-13. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Llamas MA, Imperi F, Visca P, Lamont IL. FEMS Microbiol Rev. 2014;38:569–597. doi: 10.1111/1574-6976.12078. [DOI] [PubMed] [Google Scholar]
- 53.Kaneko Y, Thoendel M, Olakanmi O, Britigan BE, Singh PK. The Journal of clinical investigation. 2007;117:877–888. doi: 10.1172/JCI30783. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Marguerettaz M, Dieppois G, Que YA, Ducret V, Zuchuat S, Perron K. Microb Pathog. 2014;77:36–41. doi: 10.1016/j.micpath.2014.10.011. [DOI] [PubMed] [Google Scholar]
- 55.F. J. I. Ellison ML, Parrish W, Danell AS, Pesci EC. PloS one. 2013;8:e75389. doi: 10.1371/journal.pone.0075389. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56.Visca P, Bonchi C, Minandri F, Frangipani E, Imperi F. Antimicrob Agents Chemother. 2013;57:2432–2433. doi: 10.1128/AAC.02529-12. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57.Cerasi M, Liu JZ, Ammendola S, Poe AJ, Petrarca P, Pesciaroli M, Pasquali P, Raffatellu M, Battistoni A. Metallomics. 2014;6:845–853. doi: 10.1039/c3mt00352c. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58.Gray RD, Duncan A, Noble D, Imrie M, O'Reilly DS, Innes JA, Porteous DJ, Greening AP, Boyd AC. Chest. 2010;137:635–641. doi: 10.1378/chest.09-1047. [DOI] [PubMed] [Google Scholar]
- 59.Corbett D, Wang J, Schuler S, Lopez-Castejon G, Glenn S, Brough D, Andrew PW, Cavet JS, Roberts IS. Infection and. 2012;80:14–21. doi: 10.1128/IAI.05904-11. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60.Lewinson O, Lee AT, Rees DC. Proceedings of the National Academy of Sciences of the United States of America. 2009;106:4677–4682. doi: 10.1073/pnas.0900666106. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61.Damron FH, Goldberg JB. Molecular microbiology. 2012;84:595–607. doi: 10.1111/j.1365-2958.2012.08049.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62.Leid JG, Willson CJ, Shirtliff ME, Hassett DJ, Parsek MR, Jeffers AK. J Immunol. 2005;175:7512–7518. doi: 10.4049/jimmunol.175.11.7512. [DOI] [PubMed] [Google Scholar]
- 63.Govan JR, Fyfe JA. J Antimicrob Chemother. 1978;4:233–240. doi: 10.1093/jac/4.3.233. [DOI] [PubMed] [Google Scholar]
- 64.Bragonzi A, Worlitzsch D, Pier GB, Timpert P, Ulrich M, Hentzer M, Andersen JB, Givskov M, Conese M, Doring G. J Infect Dis. 2005;192:410–419. doi: 10.1086/431516. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 65.Hassett DJ. J Bacteriol. 1996;178:7322–7325. doi: 10.1128/jb.178.24.7322-7325.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 66.Guzzo J, Duong F, Wandersman C, Murgier M, Lazdunski A. Mol Microbiol. 1991;5:447–453. doi: 10.1111/j.1365-2958.1991.tb02128.x. [DOI] [PubMed] [Google Scholar]
- 67.Ma Q, Zhai Y, Schneider JC, Ramseier TM, Saier MH., Jr. Biochim Biophys Acta. 2003;1611:223–233. doi: 10.1016/s0005-2736(03)00059-2. [DOI] [PubMed] [Google Scholar]
- 68.Waldron KJ, Robinson NJ. Nature reviews. Microbiology. 2009;7:25–35. doi: 10.1038/nrmicro2057. [DOI] [PubMed] [Google Scholar]
- 69.Delepelaire P. Biochim Biophys Acta. 2004;1694:149–161. doi: 10.1016/j.bbamcr.2004.05.001. [DOI] [PubMed] [Google Scholar]
- 70.Blaby-Haas CE, Furman R, Rodionov DA, Artsimovitch I, de Crécy-Lagard V. Mol Microbiol. 2011;79:700–715. doi: 10.1111/j.1365-2958.2010.07475.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 71.Panina EM. Proceedings of the National Academy of Sciences. 2003;100:9912–9917. doi: 10.1073/pnas.1733691100. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 72.Lim CK, Hassan KA, Penesyan A, Loper JE, Paulsen IT. Environmental microbiology. 2013;15:702–715. doi: 10.1111/j.1462-2920.2012.02849.x. [DOI] [PubMed] [Google Scholar]
- 73.He J, Baldini RL, Deziel E, Saucier M, Zhang Q, Liberati NT, Lee D, Urbach J, Goodman HM, Rahme LG. Proc Natl Acad Sci U S A. 2004;101:2530–2535. doi: 10.1073/pnas.0304622101. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.



